• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Does glatiramer acetate increase suicide rates in patients with MS?

Quote

anonymous

Guest
We have had two separate reports of suicides and psychiatric events in our small town. Both cases after the patients were required to change from the brand glatiramer acetate to the bioequivalent. Are either company seeing increases in rates of suicides or psychosis in patients on these therapies, similar to what they see in interferon beta 1?
 




anonymous said:
We have had two separate reports of suicides and psychiatric events in our small town. Both cases after the patients were required to change from the brand glatiramer acetate to the bioequivalent. Are either company seeing increases in rates of suicides or psychosis in patients on these therapies, similar to what they see in interferon beta 1?
Click to expand...

Report it:
MedWatch Online Voluntary Reporting Form
 




Top Bottom
Back
Quote